Quanex Building Products Corporation (NX)
NYSEIndustrialsConstruction MaterialsSnapshot 2026-10-29
$20.67-0.43%
Close 2026-10-30 · 1-day change
NYSEIndustrialsConstruction MaterialsSnapshot 2026-10-29
Research Workspace
Put NX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Building Products is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue grows at least 1.8% in next 12 months: Comparison needs review.
View ThesisManagement screens weak on capital allocation, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 31% in its worst 12-month stretch.
View RiskNX's case rests on steady revenue growth, supported by strong recent financial performance. Revenue growth slowed from 2.2% to 1.3% year over year, despite the latest earnings beat. NX trades at 11× P/E versus a 19× peer median. The price reflects less growth than our forecast. The next-quarter miss probability is 26%. The revenue-growth pillar needs review, so its status remains unverified. Peer multiples imply a price roughly in line with where it trades (about fair); the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. NX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 2 analysts currently covering NX (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare NX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| NX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Building Products — fair value, gap to price, and forward P/E.
Compare the value case
Put NX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Prioritize debt repayment and opportunistic share repurchases
Discussion on debt repayment aligns with management's priorities.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Advances: Achieve Adjusted EBITDA of $240M to $245M for fiscal 2026
Better-than-expected results support EBITDA guidance.
Advances: Achieve revenue guidance of $1.84B to $1.87B for fiscal 2026
Q4 growth aligns with revenue guidance for fiscal 2026.
Advances: Achieve Adjusted EBITDA of $240M to $245M for fiscal 2026
Earnings call may provide insights on EBITDA performance.
Advances: Achieve revenue guidance of $1.84B to $1.87B for fiscal 2026
Earnings beat supports revenue guidance for fiscal 2026.
Advances: Achieve Adjusted EBITDA of $240M to $245M for fiscal 2026
Earnings beat indicates strong EBITDA performance.
Advances: Achieve revenue guidance of $1.84B to $1.87B for fiscal 2026
Q3 results support revenue growth towards fiscal 2026 guidance.
Earnings call confirms revenue and EBITDA guidance.